Skip to content

Delayed Dinner, Exercise and Glucose Metabolism

Impact of Exercise on Metabolic Health Following Delayed Dinner Consumption in Healthy Adults

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05795205
Enrollment
12
Registered
2023-04-03
Start date
2022-04-15
Completion date
2023-08-15
Last updated
2023-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delayed Dinner, Exercise Plus Delayed Dinner, Normal Dinner

Keywords

late dinner, postprandial Glycaemia

Brief summary

This study aims to investigate whether exercise can alleviate the impact of delayed dinner on metabolic health next morning in sedentary healthy adults

Interventions

BEHAVIORALNormal dinner

Participants will consume breakfast at 0830-0855 am, lunch at 1230-1255 pm, followed by dinner at 1800-1825 pm. Snacks will be consumed at 2130-2140 pm.

BEHAVIORALDelayed dinner consumption

Participants will consume breakfast at 08:30-08:55 am, lunch at 12:30-12:55 pm, followed by snacks at 18:00-18:10 pm. Dinner will be consumed at 21:30-21:55 pm.

BEHAVIORALExercise with delayed dinner consumption

Participants will consume breakfast at 08:30-08:55 am, lunch at 12:30-12:55 pm, followed by snacks at 18:00-18:10 pm. Participants will exercise for 45 min at moderate-intensity 45 min prior to the delayed dinner at 21:30-21:55 pm.

Sponsors

National Taiwan Normal University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Physical inactive males * Weight stable for more than 3 months (no change in weight +/- 3%) * Non-smoker * Able to walk comfortably on a treadmill * Dinner consumers with normal sleep pattern (cycles)

Exclusion criteria

* Personal history of/existing diabetes, cardiovascular disease, metabolic disease or dyslipidaemia * Taking medications that may influence lipid or carbohydrate metabolism or immune system function * Unable to take part in exercise for any reason (e.g., injury or disability) or a positive response to any questions on the Physical Activity Readiness questionnaire (PAR-Q)

Design outcomes

Primary

MeasureTime frameDescription
Metabolic health (Oral glucose tolerance test, OGTT)120 minutesFasting and postprandial blood glucose responses on next morning between trials

Secondary

MeasureTime frameDescription
Visual analogue scale (VSA)120 minutesChanges in VAS from 0-100 mm (e.g., appetite & mood, etc.) on next morning between trials
Substate oxidation120 minutesLipid and carbohydrate oxidation during OGTT between trials
Blood pressure120 minutesChanges in blood pressure (systolic and diastolic blood pressure) on next morning between trials
InflammationBaselineFasting inflammatory biomarkers (IL-6, TNF-a, CRP) on next morning between trials
HRVBaselineHeart rate variability on next morning between trial
Gut hormones120 minutesChanges in blood gut hormones responses on next morning (e.g., GLP-1, PYY and GIP) between trials
Appetite (lunch intake)30 minutesAb libitum energy intake on next morning by the end of trial

Countries

Taiwan

Contacts

Primary ContactYung-Chih Chen
yc.chen@ntnu.edu.tw+886277496979
Backup ContactChen
yc.chen@ntnu.edu.tw

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026